I should clarify that I am not completely against Sativex. I generally support anything that has the potential to help people however, my primary issue with Sativex is that the cost prevents it from reaching many who could benefit from it. It's already a problem in the UK where there are many complaints from MS patients (for which it is approved) who can successfully obtain a prescription from their neuro but since the NHS doesn't cover it, they have to pay 550 British Pounds (or $900 USD) out-of-pocket for a 4-6 week supply. That's a problem.